MEDICINE: GENELUX’S TREATMENT SOON TO BE TESTED FOR EFFECTIVENESS
Cancer Therapy Aims To Hit Its Intended Target Only
Monday, June 11, 2012
Aladar Szalay
GENELUX CORP.
CEO: Aladar Szalay.
Revenue: Not disclosed.
No. of local employees: 23.
Investors: Private.
Headquarters: San Diego, with an additional office in Tuebingen, Germany.
Year founded: 2001.
Company description: A privately held, clinical-stage biopharmaceutical company focused on developing oncolytic (cancer-killing) virus-based therapies for human and veterinary applications.
Key factors for success: Company is built on a solid foundation of scientific discovery, and holds a strong intellectual property position in the area of oncolytic virology.
An experimental virus-based cancer therapy developed by San Diego-based Genelux Corp...
Take 1 minute to subscribe and you'll get this story immediately, plus:
Already a subscriber? Sign in
- 52 weekly issues
- Subscriber-only digital content every business day, plus full access to SDBJ.com archives
- Book of Lists — the most comprehensive business resource in San Diego
- San Diego 500 — influential business leaders you need to know